Overview

  • Product nameAnti-RPL7A antibody
    See all RPL7A primary antibodies
  • Description
    Rabbit polyclonal to RPL7A
  • Tested applicationsSuitable for: IP, IHC-P, WBmore details
  • Species reactivity
    Reacts with: Mouse, Human
    Predicted to work with: Rat, Rabbit, Horse, Chicken, Guinea pig, Cow, Turkey, Pig, Xenopus laevis, Chimpanzee, Zebrafish, Rhesus monkey, Gorilla, Orangutan, Xenopus tropicalis
  • Immunogen

    Synthetic peptide corresponding to a region between residue 215 and the C-terminus (residue 266) of human RPL7A (NP_000963.1).

  • Positive control
    • Whole cell lysate from HeLa, MCF7 or 293T cells.

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
  • Storage bufferPreservative: 0.09% Sodium Azide
    Constituents: 0.1% BSA, Tris buffered saline
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab70753 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IP Use at 2-5 µg/mg of lysate.
IHC-P 1/100 - 1/500. Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
WB 1/2000 - 1/10000. Detects a band of approximately 35 kDa (predicted molecular weight: 30 kDa).

Target

Anti-RPL7A antibody images

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human colon carcinoma (left) and mouse renal cell carcinoma (right) tissues labelling RPL7A with ab70753 at 1/200 (1µg/ml). Detection: DAB.
  • All lanes : Anti-RPL7A antibody (ab70753) at 0.1 µg/ml

    Lane 1 : HeLa whole cell lysate at 20 µg
    Lane 2 : HeLa whole cell lysate at 4 µg
    Lane 3 : MCF7 whole cell lysate at 20 µg
    Lane 4 : 293T whole cell lysate at 20 µg

    Developed using the ECL technique

    Predicted band size : 30 kDa
    Observed band size : 35 kDa (why is the actual band size different from the predicted?)


    Exposure time : 5 seconds

References for Anti-RPL7A antibody (ab70753)

This product has been referenced in:
  • Yang PY  et al. Activity-based proteome profiling of potential cellular targets of Orlistat--an FDA-approved drug with anti-tumor activities. J Am Chem Soc 132:656-66 (2010). Read more (PubMed: 20028024) »

See 1 Publication for this product

Product Wall

There are currently no Abreviews or Questions for ab70753.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"